Azienda Ospedaliera Monaldi

Naples, Campania 80131

0 studies enrolling now · 3 studies all time

What they study most

Asthma, Melanoma, Solid Tumors Harboring a BRAF V600 Mutation

Studies at this site

• A Phase Ib/II Study of LGX818 in Combination With MEK162 in Adult Patients With BRAF Dependent Advanced Solid Tumors — Completed
• LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma — Completed
• A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller Medication — Completed